NVDL Financials 07/16/2014 02:02:55
NovaDel Pharma, Inc.
Period Ending Dec 31, 2010
Total Revenue 2,826
Cost of Revenue -
Gross Profit 2,826
Operating Expenses
Research and Development 2,786
Sales, General and Admin. 3,008
Non-Recurring Items -
Other -
Operating Income (2,968)
Income From Continuing Operations
Add'l Income/Expense Items 303
Earnings Before Interest and Tax (2,665)
Interest Expense 1
Earnings Before Tax (2,666)
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (2,666)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (2,666)
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders (2,666)